183 related articles for article (PubMed ID: 2859199)
1. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
[TBL] [Abstract][Full Text] [Related]
2. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
Thuillez C; Richer C; Duhazé P; Bergougnan L; Giudicelli JF
Eur J Clin Pharmacol; 1985; 29(4):405-11. PubMed ID: 3912184
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
Conner DP; Vlasses PH; Clementi RA; Oren A; Deitchman D; Ferguson RK
J Clin Pharmacol; 1987 Apr; 27(4):300-3. PubMed ID: 2890669
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the natriuretic and beta-adrenoceptor-blocking effects of tienoxolol in normal volunteers.
Berdeaux A; Loueslati E; Gerard JL; Pussard E; Giudicelli JF
Fundam Clin Pharmacol; 1988; 2(5):441-54. PubMed ID: 2906898
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
[TBL] [Abstract][Full Text] [Related]
9. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK
Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080
[TBL] [Abstract][Full Text] [Related]
10. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Bundkirchen A; Brixius K; Bölck B; Schwinger RH
J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
[TBL] [Abstract][Full Text] [Related]
11. Selective and non-selective beta-blockade in renin release.
Lammintausta R; Syvälahti E; Iisalo E; Kanto J; Mäntylä R
Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):489-96. PubMed ID: 202141
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
13. Studies on the vasodilator actions of bucindolol in the rat.
Marwood JF; Stokes GS
Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):59-68. PubMed ID: 3708914
[TBL] [Abstract][Full Text] [Related]
14. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
Yonga GO; Oyuga HW; Njeru EK
East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
Wellstein A; Palm D; Pitschner HF; Belz GG
Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Riddell JG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol.
Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI
J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
